Brief: Dawnrays Pharmaceutical Holdings Posts H1 Profit Attributable RMB166.2 Mln
23/08/2018 07:35
Aug 23 (Reuters) - Dawnrays Pharmaceutical Holdings Ltd
2348.HK :
* H1 REVENUE RMB496.9 MILLION VERSUS RMB433.5 MILLION
* HY PROFIT ATTRIBUTABLE RMB166.2 MILLION VERSUS RMB149
MILLION
* TO DECLARE AN INTERIM DIVIDEND OF HK$0.015 PER SUB-DIVIDED
SHARE
Source text for Eikon: ID:nHKS5qKLHq
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO